ID   PURT_ECOLI              Reviewed;         392 AA.
AC   P33221;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   15-MAR-2017, entry version 162.
DE   RecName: Full=Formate-dependent phosphoribosylglycinamide formyltransferase {ECO:0000305|PubMed:8117714};
DE   AltName: Full=5'-phosphoribosylglycinamide transformylase 2 {ECO:0000303|PubMed:8117714};
DE   AltName: Full=Formate-dependent GAR transformylase {ECO:0000305|PubMed:8117714};
DE            EC=2.1.2.- {ECO:0000269|PubMed:8117714, ECO:0000269|PubMed:9184151};
DE   AltName: Full=GAR transformylase 2 {ECO:0000303|PubMed:8117714};
DE            Short=GART 2 {ECO:0000303|PubMed:8117714};
DE   AltName: Full=Non-folate glycinamide ribonucleotide transformylase {ECO:0000303|PubMed:8117714};
DE   AltName: Full=Phosphoribosylglycinamide formyltransferase 2 {ECO:0000303|PubMed:8117714};
GN   Name=purT {ECO:0000303|PubMed:8117714};
GN   OrderedLocusNames=b1849, JW1838;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 2-20, FUNCTION,
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, SUBSTRATE
RP   SPECIFICITY, REACTION MECHANISM, AND PATHWAY.
RC   STRAIN=K12;
RX   PubMed=8117714; DOI=10.1021/bi00175a023;
RA   Marolewski A., Smith J.M., Benkovic S.J.;
RT   "Cloning and characterization of a new purine biosynthetic enzyme: a
RT   non-folate glycinamide ribonucleotide transformylase from E. coli.";
RL   Biochemistry 33:2531-2537(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9097040; DOI=10.1093/dnares/3.6.379;
RA   Itoh T., Aiba H., Baba T., Fujita K., Hayashi K., Inada T., Isono K.,
RA   Kasai H., Kimura S., Kitakawa M., Kitagawa M., Makino K., Miki T.,
RA   Mizobuchi K., Mori H., Mori T., Motomura K., Nakade S., Nakamura Y.,
RA   Nashimoto H., Nishio Y., Oshima T., Saito N., Sampei G., Seki Y.,
RA   Sivasundaram S., Tagami H., Takeda J., Takemoto K., Wada C.,
RA   Yamamoto Y., Horiuchi T.;
RT   "A 460-kb DNA sequence of the Escherichia coli K-12 genome
RT   corresponding to the 40.1-50.0 min region on the linkage map.";
RL   DNA Res. 3:379-392(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES,
RP   MUTAGENESIS OF GLY-162, SUBSTRATE SPECIFICITY, PATHWAY, AND REACTION
RP   MECHANISM.
RX   PubMed=9184151; DOI=10.1021/bi962961p;
RA   Marolewski A.E., Mattia K.M., Warren M.S., Benkovic S.J.;
RT   "Formyl phosphate: a proposed intermediate in the reaction catalyzed
RT   by Escherichia coli PurT GAR transformylase.";
RL   Biochemistry 36:6709-6716(1997).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-179, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=K12 / JW1106, and K12 / MG1655 / ATCC 47076;
RX   PubMed=18723842; DOI=10.1074/mcp.M800187-MCP200;
RA   Zhang J., Sprung R., Pei J., Tan X., Kim S., Zhu H., Liu C.F.,
RA   Grishin N.V., Zhao Y.;
RT   "Lysine acetylation is a highly abundant and evolutionarily conserved
RT   modification in Escherichia coli.";
RL   Mol. Cell. Proteomics 8:215-225(2009).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) IN COMPLEX WITH ATP ANALOG;
RP   BETA-FORMYL GLYCINAMIDE RIBONUCLEOTIDE AND MAGNESIUM ION, AND SUBUNIT.
RX   PubMed=10913290; DOI=10.1021/bi000926j;
RA   Thoden J.B., Firestine S., Nixon A., Benkovic S.J., Holden H.M.;
RT   "Molecular structure of Escherichia coli PurT-encoded glycinamide
RT   ribonucleotide transformylase.";
RL   Biochemistry 39:8791-8802(2000).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.05 ANGSTROMS) IN COMPLEX WITH BETA-FORMYL
RP   GLYCINAMIDE RIBONUCLEOTIDE; ATP AND MAGNESIUM ION, AND SUBUNIT.
RX   PubMed=11953435; DOI=10.1074/jbc.M202251200;
RA   Thoden J.B., Firestine S.M., Benkovic S.J., Holden H.M.;
RT   "PurT-encoded glycinamide ribonucleotide transformylase. Accommodation
RT   of adenosine nucleotide analogs within the active site.";
RL   J. Biol. Chem. 277:23898-23908(2002).
CC   -!- FUNCTION: Involved in the de novo purine biosynthesis. Catalyzes
CC       the transfer of formate to 5-phospho-ribosyl-glycinamide (GAR),
CC       producing 5-phospho-ribosyl-N-formylglycinamide (FGAR). Formate is
CC       provided by PurU via hydrolysis of 10-formyl-tetrahydrofolate.
CC       PurT is also able to cleave acetyl phosphate and carbamoyl
CC       phosphate to produce ATP with acetate and carbamate, respectively.
CC       {ECO:0000269|PubMed:8117714, ECO:0000269|PubMed:9184151}.
CC   -!- CATALYTIC ACTIVITY: Formate + ATP + 5'-phospho-ribosylglycinamide
CC       = 5'-phosphoribosyl-N-formylglycinamide + ADP + phosphate.
CC       {ECO:0000269|PubMed:8117714, ECO:0000269|PubMed:9184151}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=10.1 uM for GAR (at pH 8) {ECO:0000269|PubMed:8117714,
CC         ECO:0000269|PubMed:9184151};
CC         KM=45 uM for ATP (with formate) {ECO:0000269|PubMed:9184151};
CC         KM=77.4 uM for ATP (with acetate at pH 8)
CC         {ECO:0000269|PubMed:8117714, ECO:0000269|PubMed:9184151};
CC         KM=319 uM for formate (at pH 8) {ECO:0000269|PubMed:8117714,
CC         ECO:0000269|PubMed:9184151};
CC         KM=3.68 mM for acetate (at pH 8) {ECO:0000269|PubMed:8117714};
CC         Note=Kcat is 37.6 sec(-1) for transformylase activity (at pH 8).
CC         Kcat is 0.309 sec(-1) for acetate kinase activity (at pH 8).
CC         {ECO:0000269|PubMed:8117714};
CC   -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway;
CC       N(2)-formyl-N(1)-(5-phospho-D-ribosyl)glycinamide from N(1)-(5-
CC       phospho-D-ribosyl)glycinamide (formate route): step 1/1.
CC       {ECO:0000255|HAMAP-Rule:MF_01643, ECO:0000305|PubMed:8117714,
CC       ECO:0000305|PubMed:9184151}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:10913290,
CC       ECO:0000269|PubMed:11953435, ECO:0000305|PubMed:8117714}.
CC   -!- INTERACTION:
CC       P22939:ispA; NbExp=3; IntAct=EBI-553029, EBI-553011;
CC   -!- SIMILARITY: Belongs to the PurK/PurT family. {ECO:0000255|HAMAP-
CC       Rule:MF_01643}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L20897; AAA23861.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC74919.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA15657.1; -; Genomic_DNA.
DR   PIR; A54227; A54227.
DR   RefSeq; NP_416363.1; NC_000913.3.
DR   RefSeq; WP_000173484.1; NZ_LN832404.1.
DR   PDB; 1EYZ; X-ray; 1.75 A; A/B=1-392.
DR   PDB; 1EZ1; X-ray; 1.75 A; A/B=1-392.
DR   PDB; 1KJ8; X-ray; 1.60 A; A/B=2-392.
DR   PDB; 1KJ9; X-ray; 1.60 A; A/B=2-392.
DR   PDB; 1KJI; X-ray; 1.60 A; A/B=2-392.
DR   PDB; 1KJJ; X-ray; 1.75 A; A/B=2-392.
DR   PDB; 1KJQ; X-ray; 1.05 A; A/B=2-392.
DR   PDB; 1NFE; Model; -; A=1-392.
DR   PDBsum; 1EYZ; -.
DR   PDBsum; 1EZ1; -.
DR   PDBsum; 1KJ8; -.
DR   PDBsum; 1KJ9; -.
DR   PDBsum; 1KJI; -.
DR   PDBsum; 1KJJ; -.
DR   PDBsum; 1KJQ; -.
DR   PDBsum; 1NFE; -.
DR   ProteinModelPortal; P33221; -.
DR   SMR; P33221; -.
DR   DIP; DIP-10618N; -.
DR   IntAct; P33221; 7.
DR   MINT; MINT-1306001; -.
DR   STRING; 511145.b1849; -.
DR   DrugBank; DB03434; 3[N-Morpholino]Propane Sulfonic Acid.
DR   DrugBank; DB02236; Glycinamide Ribonucleotide.
DR   DrugBank; DB04395; Phosphoaminophosphonic Acid-Adenylate Ester.
DR   DrugBank; DB02930; Phosphothiophosphoric Acid-Adenylate Ester.
DR   PaxDb; P33221; -.
DR   PRIDE; P33221; -.
DR   EnsemblBacteria; AAC74919; AAC74919; b1849.
DR   EnsemblBacteria; BAA15657; BAA15657; BAA15657.
DR   GeneID; 946368; -.
DR   KEGG; ecj:JW1838; -.
DR   KEGG; eco:b1849; -.
DR   PATRIC; 32119019; VBIEscCol129921_1927.
DR   EchoBASE; EB1757; -.
DR   EcoGene; EG11809; purT.
DR   eggNOG; ENOG4108HH9; Bacteria.
DR   eggNOG; COG0027; LUCA.
DR   HOGENOM; HOG000072820; -.
DR   InParanoid; P33221; -.
DR   KO; K08289; -.
DR   OMA; IFGVEFF; -.
DR   PhylomeDB; P33221; -.
DR   BioCyc; EcoCyc:GARTRANSFORMYL2-MONOMER; -.
DR   BioCyc; MetaCyc:GARTRANSFORMYL2-MONOMER; -.
DR   UniPathway; UPA00074; UER00127.
DR   EvolutionaryTrace; P33221; -.
DR   PRO; PR:P33221; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0008776; F:acetate kinase activity; IDA:EcoCyc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004644; F:phosphoribosylglycinamide formyltransferase activity; IEA:InterPro.
DR   GO; GO:0006189; P:'de novo' IMP biosynthetic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.30.1490.20; -; 1.
DR   Gene3D; 3.30.470.20; -; 1.
DR   Gene3D; 3.40.50.20; -; 1.
DR   HAMAP; MF_01643; PurT; 1.
DR   InterPro; IPR011761; ATP-grasp.
DR   InterPro; IPR003135; ATP-grasp_carboxylate-amine.
DR   InterPro; IPR013815; ATP_grasp_subdomain_1.
DR   InterPro; IPR013816; ATP_grasp_subdomain_2.
DR   InterPro; IPR016185; PreATP-grasp_dom.
DR   InterPro; IPR005862; PurT.
DR   InterPro; IPR011054; Rudment_hybrid_motif.
DR   Pfam; PF02222; ATP-grasp; 1.
DR   SUPFAM; SSF51246; SSF51246; 1.
DR   SUPFAM; SSF52440; SSF52440; 1.
DR   TIGRFAMs; TIGR01142; purT; 1.
DR   PROSITE; PS50975; ATP_GRASP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Complete proteome;
KW   Direct protein sequencing; Magnesium; Metal-binding;
KW   Nucleotide-binding; Purine biosynthesis; Reference proteome;
KW   Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:8117714}.
FT   CHAIN         2    392       Formate-dependent
FT                                phosphoribosylglycinamide
FT                                formyltransferase.
FT                                /FTId=PRO_0000074956.
FT   DOMAIN      119    308       ATP-grasp. {ECO:0000255|HAMAP-
FT                                Rule:MF_01643}.
FT   NP_BIND     160    165       ATP. {ECO:0000269|PubMed:10913290,
FT                                ECO:0000269|PubMed:11953435}.
FT   NP_BIND     195    198       ATP. {ECO:0000269|PubMed:10913290,
FT                                ECO:0000269|PubMed:11953435}.
FT   REGION       22     23       5'-phosphoribosylglycinamide binding.
FT                                {ECO:0000269|PubMed:10913290,
FT                                ECO:0000269|PubMed:11953435}.
FT   REGION      362    363       5'-phosphoribosylglycinamide binding.
FT                                {ECO:0000269|PubMed:10913290,
FT                                ECO:0000269|PubMed:11953435}.
FT   METAL       267    267       Magnesium. {ECO:0000269|PubMed:10913290,
FT                                ECO:0000269|PubMed:11953435}.
FT   METAL       279    279       Magnesium. {ECO:0000269|PubMed:10913290,
FT                                ECO:0000269|PubMed:11953435}.
FT   BINDING      82     82       5'-phosphoribosylglycinamide.
FT                                {ECO:0000269|PubMed:10913290,
FT                                ECO:0000269|PubMed:11953435}.
FT   BINDING     114    114       ATP. {ECO:0000269|PubMed:10913290,
FT                                ECO:0000269|PubMed:11953435}.
FT   BINDING     155    155       ATP. {ECO:0000269|PubMed:10913290,
FT                                ECO:0000269|PubMed:11953435}.
FT   BINDING     203    203       ATP. {ECO:0000269|PubMed:10913290,
FT                                ECO:0000269|PubMed:11953435}.
FT   BINDING     286    286       5'-phosphoribosylglycinamide.
FT                                {ECO:0000269|PubMed:10913290,
FT                                ECO:0000269|PubMed:11953435}.
FT   BINDING     355    355       5'-phosphoribosylglycinamide.
FT                                {ECO:0000269|PubMed:10913290,
FT                                ECO:0000269|PubMed:11953435}.
FT   MOD_RES     179    179       N6-acetyllysine. {ECO:0000255|HAMAP-
FT                                Rule:MF_01643,
FT                                ECO:0000269|PubMed:18723842}.
FT   MUTAGEN     162    162       G->I: Strong decrease in the reaction
FT                                rate for the conversion of formate to
FT                                FGAR and in the affinity for formate. 3-
FT                                and 2-fold decrease in the affinity for
FT                                ATP and GAR, respectively.
FT                                {ECO:0000269|PubMed:9184151}.
FT   STRAND       14     19       {ECO:0000244|PDB:1KJQ}.
FT   HELIX        22     32       {ECO:0000244|PDB:1KJQ}.
FT   TURN         33     35       {ECO:0000244|PDB:1KJQ}.
FT   STRAND       37     44       {ECO:0000244|PDB:1KJQ}.
FT   HELIX        48     52       {ECO:0000244|PDB:1KJQ}.
FT   STRAND       53     58       {ECO:0000244|PDB:1KJQ}.
FT   HELIX        64     74       {ECO:0000244|PDB:1KJQ}.
FT   STRAND       77     81       {ECO:0000244|PDB:1KJQ}.
FT   HELIX        88     96       {ECO:0000244|PDB:1KJQ}.
FT   STRAND      100    103       {ECO:0000244|PDB:1KJQ}.
FT   HELIX       105    112       {ECO:0000244|PDB:1KJQ}.
FT   HELIX       114    122       {ECO:0000244|PDB:1KJQ}.
FT   STRAND      132    137       {ECO:0000244|PDB:1KJQ}.
FT   HELIX       138    148       {ECO:0000244|PDB:1KJQ}.
FT   STRAND      150    157       {ECO:0000244|PDB:1KJQ}.
FT   TURN        161    164       {ECO:0000244|PDB:1KJ8}.
FT   STRAND      166    168       {ECO:0000244|PDB:1KJQ}.
FT   HELIX       171    173       {ECO:0000244|PDB:1KJQ}.
FT   HELIX       174    184       {ECO:0000244|PDB:1KJQ}.
FT   HELIX       186    188       {ECO:0000244|PDB:1KJQ}.
FT   STRAND      192    196       {ECO:0000244|PDB:1KJQ}.
FT   STRAND      201    211       {ECO:0000244|PDB:1KJQ}.
FT   STRAND      214    217       {ECO:0000244|PDB:1KJQ}.
FT   STRAND      221    226       {ECO:0000244|PDB:1KJQ}.
FT   STRAND      229    235       {ECO:0000244|PDB:1KJQ}.
FT   HELIX       241    258       {ECO:0000244|PDB:1KJQ}.
FT   STRAND      260    271       {ECO:0000244|PDB:1KJQ}.
FT   STRAND      274    283       {ECO:0000244|PDB:1KJQ}.
FT   HELIX       286    290       {ECO:0000244|PDB:1KJQ}.
FT   HELIX       291    294       {ECO:0000244|PDB:1KJQ}.
FT   STRAND      295    297       {ECO:0000244|PDB:1KJQ}.
FT   HELIX       299    307       {ECO:0000244|PDB:1KJQ}.
FT   STRAND      319    326       {ECO:0000244|PDB:1KJQ}.
FT   STRAND      329    334       {ECO:0000244|PDB:1KJQ}.
FT   STRAND      336    338       {ECO:0000244|PDB:1KJQ}.
FT   HELIX       340    342       {ECO:0000244|PDB:1KJQ}.
FT   STRAND      348    352       {ECO:0000244|PDB:1KJQ}.
FT   STRAND      358    361       {ECO:0000244|PDB:1KJQ}.
FT   STRAND      365    370       {ECO:0000244|PDB:1KJQ}.
FT   HELIX       374    387       {ECO:0000244|PDB:1KJQ}.
FT   STRAND      389    391       {ECO:0000244|PDB:1KJQ}.
SQ   SEQUENCE   392 AA;  42434 MW;  276B3883E7403EA9 CRC64;
     MTLLGTALRP AATRVMLLGS GELGKEVAIE CQRLGVEVIA VDRYADAPAM HVAHRSHVIN
     MLDGDALRRV VELEKPHYIV PEIEAIATDM LIQLEEEGLN VVPCARATKL TMNREGIRRL
     AAEELQLPTS TYRFADSESL FREAVADIGY PCIVKPVMSS SGKGQTFIRS AEQLAQAWKY
     AQQGGRAGAG RVIVEGVVKF DFEITLLTVS AVDGVHFCAP VGHRQEDGDY RESWQPQQMS
     PLALERAQEI ARKVVLALGG YGLFGVELFV CGDEVIFSEV SPRPHDTGMV TLISQDLSEF
     ALHVRAFLGL PVGGIRQYGP AASAVILPQL TSQNVTFDNV QNAVGADLQI RLFGKPEIDG
     SRRLGVALAT AESVVDAIER AKHAAGQVKV QG
//
